Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation. - Test2 - elhamkhani - TriplyDB

Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.

Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.

http://www.wikidata.org/entity/Q36114167

about

Epithelial Anion Transport as Modulator of Chemokine Signaling The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules.An Efficient Power Harvesting Mobile Phone-Based Electrochemical Biosensor for Point-of-Care Health Monitoring Smartphone-Based pH Sensor for Home Monitoring of Pulmonary Exacerbations in Cystic Fibrosis.Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression.Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.Potential of anti-inflammatory treatment for cystic fibrosis lung disease.A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammation.Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1 Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease Cystic fibrosis: a mucosal immunodeficiency syndrome.Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers.Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation.Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.The cystic fibrosis neutrophil: a specialized yet potentially defective cell.The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.SLPI and inflammatory lung disease in females.SLPI and elafin: multifunctional antiproteases of the WFDC family.Inflammation and its genesis in cystic fibrosis.Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection.The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity.Cystic Fibrosis: Microbiology and Host Response Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.A secretory leukocyte protease inhibitor variant with improved activity against lung infection.A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lung.Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas aeruginosa-induced pneumonia.17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor.The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.α1-Antitrypsin deficiency.Cervical Expression of Elafin and SLPI in Pregnancy and Their Association With Preterm Labor.Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase.The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.

P2860

Q26744381-39CE589C-0BB8-43A2-A6BC-184A4D85F72A Q26799771-97771B20-1FD9-4DEA-837A-B528ED8BCE07 Q30599952-F8F683CE-A017-4282-AFCA-40650C492C42 Q33451060-70B5889D-7997-4D97-9D92-2EC6F51A6292 Q33454731-56186972-F58D-4709-859D-3B8763625012 Q33911933-926E8D16-C39B-4289-914F-63920B365D29 Q34036615-29703630-9DDE-4E7E-8B35-8D5E7A7166BC Q34058642-0756EAD7-A14F-4AF7-A042-77C9D12C6D64 Q34480433-D06AFB51-A042-4B35-AB84-F68515265B07 Q35557381-AFCC72A7-38FA-4D1E-BD9E-DC89F0E6ADD6 Q35591399-A3AC4446-E7C5-4CD3-AF98-5AF83B6B93CF Q35597064-D7061D89-AE64-4137-BDCB-57FC2F068CC5 Q35817400-650F8C5C-CE80-4EAB-87B8-933DDD066E1A Q36104532-448B9643-0E0D-4A63-A55E-E93D9E1A44AD Q36488723-D4E3F9A8-5F6A-4351-8D77-7336345E1924 Q36623329-9BD2FF68-91AA-4B1D-B3AB-E4219812E72E Q37334286-9971A2C0-2AE6-4252-85BC-1B0DFC78FBAF Q37576058-47514AC9-75A9-479A-B301-D7B1A46F851C Q37631563-C90E96CA-BDAA-4B91-A0C7-7703E6B77F50 Q37731798-57DBB4A5-B14F-4857-A414-35C6CBCF6CE2 Q37839809-BF237F36-5183-48F7-816E-02807EA4724E Q37894093-6AE19DE5-CE7A-4D4C-94B8-D5DA4D7FDFE7 Q37936535-6C04E156-6E4E-4CD9-B583-C985E4D0CF6B Q37936541-A222DF5A-D7DD-495C-96CB-18A29599F285 Q38579962-D4669C03-C5B2-4ABE-BD25-8BE32BE7BEE4 Q38683678-13D1D91B-D04C-4004-9FDD-21B830AB28FB Q38823607-5F985526-56E5-4479-A55D-31F367C12018 Q38845999-B3E2DC04-A2C6-4474-A90C-EAC8B1EC4D5A Q38911644-DC87D818-6A78-4FAC-8CFD-80061735ADA5 Q40625603-8A58700A-9E0E-4034-9E39-81318A831B5B Q40996531-51043D21-3425-45FD-800D-46979216C9B5 Q41431968-DBCAD167-3A36-4945-BB1E-CFBD9FDDAF65 Q41895067-4F064982-FAF7-4A4C-A935-3DBA280E28BF Q43105666-ACB3D1EE-0CBE-47E2-816D-9B7C9A31F64A Q51465407-BDE6B135-E3A7-48D3-9AB7-F6A83796D18E Q51481224-79BCEB85-597D-4F56-A02D-25144C0F23BD Q53652965-D99342CE-B664-4903-BB46-191C876600E5 Q54974556-A69F9B2E-D602-4B73-95BA-A9CE3C9D690F Q55011363-43D8F78E-C76F-4CE1-8D3B-68AE4051193D

P2860

Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.

http://www.wikidata.org/entity/Q36114167

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Decreased levels of secretory ...... utrophil elastase degradation.

@ast

Decreased levels of secretory ...... utrophil elastase degradation.

@en

type

label

Decreased levels of secretory ...... utrophil elastase degradation.

@ast

Decreased levels of secretory ...... utrophil elastase degradation.

@en

prefLabel

Decreased levels of secretory ...... utrophil elastase degradation.

@ast

Decreased levels of secretory ...... utrophil elastase degradation.

@en

P1433

Q36114167-A5555730-34C8-4A74-8A45-35DD953BC3E6

P1476

Q36114167-A714C02C-1A79-4FA3-98BF-2835A16E9D3A

P2093

Q36114167-1E9939EE-DD55-4752-9155-842FD125AF37

Q36114167-4C14B574-4D81-423B-86A3-7784E2F2CD53

Q36114167-998DA7B9-AA8C-4153-977D-C54C9A427614

Q36114167-D3D14865-52D2-408D-B8A0-68716A25FB25

Q36114167-EA4DAAC1-257B-45ED-B0B3-327AFF6F29EE

P2860

Q36114167-0C923F44-C335-4236-9A03-63A0D13E822C

Q36114167-1AC30D29-557F-4B28-B426-4AE627CC15A6

Q36114167-20375546-76FF-4998-8E78-85032B45B03F

Q36114167-20B5424F-A2AF-4151-B321-5C7F3F1DE531

Q36114167-29E037C0-7DA6-44E6-AC3A-28B8E7FB82F5

Q36114167-2D84360C-A5B9-4A26-99C4-D67DBA792D74

Q36114167-31C9C73B-E77E-4817-B63B-921DF9629686

Q36114167-391A4F97-BE4E-4C85-9E11-190D7ABF9E2A

Q36114167-3F4A9C11-8B5C-4071-A043-BE289A11C4E0

Q36114167-4BED9626-E09E-4AFA-8172-67380EAFAC01

P304

Q36114167-AEE34227-8C7B-4CF0-8FED-8EBDC95D893A

P31

Q36114167-6863246C-58F8-425B-990C-CFA53B666BD8

P356

Q36114167-2A29C5E7-47C4-4949-8B88-8B1E54C29CC4

P407

Q36114167-59E2DD61-1299-41AB-8F61-A11250C26FA7

P433

Q36114167-1A702D43-FDD6-4D6B-B07E-4E123C2C3ACC

P478

Q36114167-4AD17D02-544D-4931-842F-94D84D1327D4

P50

Q36114167-1E0AA493-40F7-46BF-AD21-904CA13C5D26

Q36114167-235D4742-2650-456D-B647-A24D15120372

Q36114167-235E5487-9000-45B2-A9C4-989ADF37EAE7

Q36114167-8D265191-A116-41EF-B246-19BFF05F1A91

P577

Q36114167-450705A6-B152-4AA7-AD04-8F911336A25B

P5875

Q36114167-8626EAD1-97A7-43D3-B98D-A9EBD63E4552

P698

Q36114167-97B3FA56-D12B-4BD3-8972-937009AB4005

P921

Q36114167-F69F0C0E-E829-44EB-A8FF-FE8AE20338A8

P932

Q36114167-C65AF541-A84D-4B4F-B941-D29BBAFF338A

P356

JIMMUNOL.0901716

P1433

Journal of Immunology

P1476

Decreased levels of secretory ...... utrophil elastase degradation.

@en

P2093

Abderrazzaq Belaaouaj

http://www.w3.org/2001/XMLSchema#string

Danny F McAuley

http://www.w3.org/2001/XMLSchema#string

Julien Wartelle

http://www.w3.org/2001/XMLSchema#string

Noel G McElvaney

http://www.w3.org/2001/XMLSchema#string

Rodney L Levine

http://www.w3.org/2001/XMLSchema#string

P2860

The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease

The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor

Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor

The whey acidic protein family: a new signature motif and three-dimensional structure by comparative modeling

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

Transcriptional response of bronchial epithelial cells to Pseudomonas aeruginosa: identification of early mediators of host defense

Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice

Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.

Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands.

Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.

P304

8148-8156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0901716

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

183

http://www.w3.org/2001/XMLSchema#string

P50

Clifford C Taggart

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40685337

http://www.w3.org/2001/XMLSchema#string

P698

20007580

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

3404409

http://www.w3.org/2001/XMLSchema#string